A new study published in the Journal of Affective Disorders has found that adults with major depression show specific ...
Although a plethora of medications and therapies now exist for major depression, roughly one in three diagnosed patients ...
Recognizing how persistent depressive disorder manifests and plays out in the lives of individuals is the first step in ...
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...
A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...
Dynamic interpersonal therapy (DIT) is a short-term psychodynamic psychotherapy that has been shown to effectively reduce depressive symptoms in patients with major depressive disorder (MDD). In DIT, ...
Unlike standalone MDD, where depressive episodes come and go, or PDD, which lingers at a lower intensity, double depression ...
In this article, we look at how this condition develops, who might be at risk, and the available treatment options. People with SAD, or major depressive disorder with seasonal pattern, experience ...
The FDA has cleared Magstim Horizon 3.0 TMS Therapy System as an adjunct for the treatment of MDD in adolescent patients aged 15 to 21 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback